About Apollomics, Inc.
http://www.apollomicsinc.comApollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
CEO
Guo-Liang Yu
Compensation Summary
(Year )
Ratings Snapshot
Rating : B-
Price Target
Institutional Ownership
CLEAR STREET GROUP INC.
Shares:1M
Value:$14.86K
CLEAR STREET LLC
Shares:506.79K
Value:$7.5K
CLEAR STREET DERIVATIVES LLC
Shares:497.35K
Value:$7.36K
Summary
Showing Top 3 of 17
About Apollomics, Inc.
http://www.apollomicsinc.comApollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $8.5M ▲ | $19.11M ▲ | $-12.54M ▲ | -147.48% ▼ | $-11.37 ▲ | $-12.5M ▲ |
| Q4-2024 | $-1.57M ▼ | $15.26M ▼ | $-18.65M ▲ | 1.19K% ▲ | $-16.92 ▲ | $-15.78M ▲ |
| Q2-2024 | $1.77M ▲ | $27.08M ▼ | $-35.21M ▼ | -1.99K% ▲ | $-37.56 ▼ | $-25.28M ▲ |
| Q4-2023 | $333K ▼ | $28.66M ▲ | $-21.91M ▲ | -6.58K% ▲ | $-0.24 ▲ | $-27.82M ▼ |
| Q2-2023 | $488K | $26.17M | $-150.69M | -30.88K% | $-2.56 | $-25.62M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $2.09M ▼ | $11.12M ▼ | $15.52M ▲ | $-4.4M ▼ |
| Q4-2024 | $9.77M ▼ | $13.1M ▼ | $8.23M ▼ | $4.86M ▼ |
| Q2-2024 | $25.93M ▼ | $34.57M ▼ | $13.77M ▼ | $20.81M ▼ |
| Q4-2023 | $37.82M ▼ | $55.39M ▼ | $14.15M ▼ | $41.23M ▼ |
| Q2-2023 | $52.62M | $71.38M | $15.68M | $55.7M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2024 | $-18.65M ▲ | $-12.76M ▲ | $236K ▼ | $-3.65M ▼ | $0 | $-12.76M ▲ |
| Q2-2024 | $-35.21M ▼ | $-15.99M ▲ | $5.75M ▼ | $4.12M ▲ | $0 | $-16.01M ▲ |
| Q4-2023 | $-21.91M ▲ | $-18.81M ▲ | $21.61M ▲ | $3.98M ▼ | $0 | $-18.81M ▲ |
| Q2-2023 | $-150.69M ▲ | $-24.4M ▼ | $-242K ▼ | $17.24M ▲ | $0 ▲ | $-24.4M ▼ |
| Q4-2022 | $-237.39M | $-23.1M | $5.21M | $-141K | $-50.7M | $-23.13M |
CEO
Guo-Liang Yu
Compensation Summary
(Year )
Ratings Snapshot
Rating : B-
Price Target
Institutional Ownership
CLEAR STREET GROUP INC.
Shares:1M
Value:$14.86K
CLEAR STREET LLC
Shares:506.79K
Value:$7.5K
CLEAR STREET DERIVATIVES LLC
Shares:497.35K
Value:$7.36K
Summary
Showing Top 3 of 17